Understanding the Role of BCMA-Targeted CAR-T Therapies in R/R MM
Noopur Raje, MD discusses the rationale for utilizing BCMA-targeted CAR-T cell therapy in myeloma patients and uncover the similarities and differences when compared to BCMA bispecific.
Source: onclive.com